IGHMBP2 and Charcot-Marie-Tooth disease axonal type 2S: These observations are in line with many previous studies revealing that patients with SMARD1 or CMT2S are not distinguishable at the genetic level, whereas a correlation between mutations at the protein level and clinical severity remains unclear (4, 16, 17).